Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation

Journal Article · · Biochemical and Biophysical Research Communications
OSTI ID:20798828
 [1];  [1];  [1];  [1];  [1];  [1];  [1];  [2];  [1]
  1. Department of Radiation Research, Faculty of Medicine, University of Tokyo, Tokyo 113-0033 (Japan)
  2. Department of Radiology, Faculty of Medicine, University of Tokyo, Tokyo 113-0033 (Japan)

Exposure of MDA-MB-468 cells to ionizing radiation (IR) caused biphasic activation of ERK as indicated by its phosphorylation at Thr202/Tyr204. Specific epidermal growth factor receptor (EGFR) inhibitor AG1478 and specific Src inhibitor PP2 inhibited IR-induced ERK1/2 activation but phosphatidylinositol-3 kinase inhibitor wortmannin did not. IR caused EGFR tyrosine phosphorylation, whereas it did not induce EGFR autophosphorylation at Tyr992, Tyr1045, and Tyr1068 or Src-dependent EGFR phosphorylation at Tyr845. SHP-2, which positively regulates EGFR/Ras/ERK signaling cascade, became activated by IR as indicated by its phosphorylation at Tyr542. This activation was inhibited by PP2 not by AG1478, which suggests Src-dependent activation of SHP-2. Src and PTP{alpha}, which positively regulates Src, became activated as indicated by phosphorylation at Tyr416 and Tyr789, respectively. These data suggest that IR-induced ERK1/2 activation involves EGFR through a Src-dependent pathway that is distinct from EGFR ligand activation.

OSTI ID:
20798828
Journal Information:
Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 2 Vol. 341; ISSN 0006-291X; ISSN BBRCA9
Country of Publication:
United States
Language:
English